Understanding 2017 Regulatory Convergence
Exploring 2017 Regulatory Convergence reveals several interesting facts. There are many great reasons to attend the
Key Takeaways about 2017 Regulatory Convergence
- Thanks to technology and innovative thinking, we're now at a point where we can help to make personalized experiences a reality ...
- Janet Woodcock, director of the US Food and Drug Administration's Center for Drug Evaluation and Research spoke to attendees ...
- The
- The objective of this international
- Thank you to all who joined us for
Detailed Analysis of 2017 Regulatory Convergence
US Food and Drug Administration Commissioner Scott Gottlieb addressed attendees of RAPS' Artificial Intelligence (AI) is a breakthrough technology which is just now being applied to medical devices to make them smarter. On June 21,
Hear from Janet Woodcock, director for US FDA's Center for Drug Evaluation and Research (CDER) about recent activities and ...
Stay tuned for more updates related to 2017 Regulatory Convergence.